BUDZ Highlights Valuable Legacy Genetics Portfolio Following Historic Federal Schedule III Marijuana Action WEED Inc. (OTCQB:BUDZ) Positioned with Rare Landrace Strains as DOJ Announces Immediate Schedule III Pathway for Qualified Medical Marijuana
TUCSON, AZ / ACCESS Newswire / April 23, 2026 / WEED Inc. (OTCQB:BUDZ) ("BUDZ" or the "Company"), a cannabis bioresearch and genetics-focused public company, today issued a strategic corporate update following the U.S. Department of Justice and Drug Enforcement Administration announcement placing FDA-approved marijuana products and marijuana...